Rank | Gene Set | Z-score |
---|---|---|
1 | synaptic vesicle maturation (GO:0016188) | 4.48021856 |
2 | sodium ion export (GO:0071436) | 4.40788533 |
3 | locomotory exploration behavior (GO:0035641) | 4.29739462 |
4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.88357950 |
5 | semaphorin-plexin signaling pathway (GO:0071526) | 3.72061667 |
6 | cell-cell junction maintenance (GO:0045217) | 3.72028353 |
7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.54887158 |
8 | lysine catabolic process (GO:0006554) | 3.54718568 |
9 | lysine metabolic process (GO:0006553) | 3.54718568 |
10 | layer formation in cerebral cortex (GO:0021819) | 3.53842189 |
11 | activation of Rac GTPase activity (GO:0032863) | 3.51111924 |
12 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.47093256 |
13 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.39247585 |
14 | regulation of cholesterol homeostasis (GO:2000188) | 3.37943054 |
15 | glutamate secretion (GO:0014047) | 3.37837105 |
16 | mannose metabolic process (GO:0006013) | 3.37574403 |
17 | adherens junction assembly (GO:0034333) | 3.37387801 |
18 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.35692358 |
19 | negative regulation of fatty acid transport (GO:2000192) | 3.34618104 |
20 | vocalization behavior (GO:0071625) | 3.32525383 |
21 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.30587541 |
22 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.29178746 |
23 | focal adhesion assembly (GO:0048041) | 3.27340437 |
24 | cell-substrate adherens junction assembly (GO:0007045) | 3.27340437 |
25 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.26924477 |
26 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.26060446 |
27 | regulation of ARF protein signal transduction (GO:0032012) | 3.24590170 |
28 | cell communication by electrical coupling (GO:0010644) | 3.24127191 |
29 | regulation of synapse structural plasticity (GO:0051823) | 3.17144029 |
30 | alpha-linolenic acid metabolic process (GO:0036109) | 3.13612232 |
31 | activation of protein kinase A activity (GO:0034199) | 3.13139130 |
32 | positive regulation of CREB transcription factor activity (GO:0032793) | 3.12447384 |
33 | apoptotic process involved in morphogenesis (GO:0060561) | 3.09870351 |
34 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.08968233 |
35 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 3.08131551 |
36 | endothelial cell chemotaxis (GO:0035767) | 3.06682902 |
37 | cellular potassium ion homeostasis (GO:0030007) | 3.00807637 |
38 | positive regulation of fibroblast migration (GO:0010763) | 2.99693825 |
39 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.98553048 |
40 | adhesion of symbiont to host (GO:0044406) | 2.96162621 |
41 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.95789427 |
42 | negative regulation of catenin import into nucleus (GO:0035414) | 2.94690065 |
43 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.92272947 |
44 | cell-substrate junction assembly (GO:0007044) | 2.88538444 |
45 | regulation of ARF GTPase activity (GO:0032312) | 2.87001016 |
46 | cell junction maintenance (GO:0034331) | 2.86533009 |
47 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.86413887 |
48 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.85627353 |
49 | negative regulation of cell size (GO:0045792) | 2.84813452 |
50 | adhesion of symbiont to host cell (GO:0044650) | 2.83735624 |
51 | virion attachment to host cell (GO:0019062) | 2.83735624 |
52 | glutamate metabolic process (GO:0006536) | 2.83373904 |
53 | desmosome organization (GO:0002934) | 2.82704324 |
54 | synaptic vesicle exocytosis (GO:0016079) | 2.82546236 |
55 | aspartate family amino acid catabolic process (GO:0009068) | 2.82050375 |
56 | positive regulation of fatty acid oxidation (GO:0046321) | 2.81565507 |
57 | atrioventricular valve morphogenesis (GO:0003181) | 2.80979697 |
58 | neurotransmitter secretion (GO:0007269) | 2.80746147 |
59 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.80687469 |
60 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.80608593 |
61 | exploration behavior (GO:0035640) | 2.79285677 |
62 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.77852656 |
63 | regulation of synapse maturation (GO:0090128) | 2.77749720 |
64 | cell communication involved in cardiac conduction (GO:0086065) | 2.77681001 |
65 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.76173963 |
66 | cell migration in hindbrain (GO:0021535) | 2.75941304 |
67 | dendritic spine morphogenesis (GO:0060997) | 2.73012728 |
68 | dopamine receptor signaling pathway (GO:0007212) | 2.72179182 |
69 | proline transport (GO:0015824) | 2.72055336 |
70 | epithelial cell-cell adhesion (GO:0090136) | 2.71794144 |
71 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.71299117 |
72 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.70436738 |
73 | alanine transport (GO:0032328) | 2.69748791 |
74 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.65821506 |
75 | striated muscle atrophy (GO:0014891) | 2.64822221 |
76 | positive regulation of protein dephosphorylation (GO:0035307) | 2.64417970 |
77 | basement membrane organization (GO:0071711) | 2.63612015 |
78 | 2-oxoglutarate metabolic process (GO:0006103) | 2.63519558 |
79 | glycine transport (GO:0015816) | 2.63197043 |
80 | negative regulation of cholesterol transport (GO:0032375) | 2.63069823 |
81 | negative regulation of sterol transport (GO:0032372) | 2.63069823 |
82 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.60579435 |
83 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.59396048 |
84 | L-phenylalanine metabolic process (GO:0006558) | 2.59396048 |
85 | neuromuscular process controlling balance (GO:0050885) | 2.57358480 |
86 | regulation of synaptic vesicle transport (GO:1902803) | 2.57001672 |
87 | L-phenylalanine catabolic process (GO:0006559) | 2.56768159 |
88 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.56768159 |
89 | gamma-aminobutyric acid transport (GO:0015812) | 2.56236299 |
90 | cellular response to pH (GO:0071467) | 2.54950189 |
91 | protein retention in ER lumen (GO:0006621) | 2.54547255 |
92 | hemidesmosome assembly (GO:0031581) | 2.53785159 |
93 | potassium ion import (GO:0010107) | 2.53346776 |
94 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.52555313 |
95 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.52470984 |
96 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.51219898 |
97 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.51194024 |
98 | positive regulation of histone deacetylation (GO:0031065) | 2.51169722 |
99 | cellular sodium ion homeostasis (GO:0006883) | 2.50012707 |
100 | cerebellar Purkinje cell layer development (GO:0021680) | 2.49646623 |
101 | cellular modified amino acid catabolic process (GO:0042219) | 2.46966795 |
102 | positive regulation of synapse maturation (GO:0090129) | 2.46893634 |
103 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.46796692 |
104 | urea metabolic process (GO:0019627) | 2.45216579 |
105 | urea cycle (GO:0000050) | 2.45216579 |
106 | skeletal muscle adaptation (GO:0043501) | 2.44862512 |
107 | kynurenine metabolic process (GO:0070189) | 2.43777974 |
108 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.43011222 |
109 | plasma membrane repair (GO:0001778) | 2.42434800 |
110 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.41847633 |
111 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.41610587 |
112 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.40551619 |
113 | actin filament depolymerization (GO:0030042) | 2.39972765 |
114 | actin filament bundle organization (GO:0061572) | 2.39898192 |
115 | actin filament bundle assembly (GO:0051017) | 2.39898192 |
116 | positive regulation of protein deacetylation (GO:0090312) | 2.39545667 |
117 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.39010304 |
118 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.38458762 |
119 | myelin maintenance (GO:0043217) | 2.38405771 |
120 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.38019825 |
121 | neural tube development (GO:0021915) | 2.37764962 |
122 | phosphate ion transmembrane transport (GO:0035435) | 2.37312115 |
123 | protein localization to endosome (GO:0036010) | 2.36786880 |
124 | cysteine metabolic process (GO:0006534) | 2.36125610 |
125 | activation of MAPKKK activity (GO:0000185) | 2.35878668 |
126 | regulation of extracellular matrix disassembly (GO:0010715) | 2.35750818 |
127 | stress fiber assembly (GO:0043149) | 2.35515998 |
128 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.35464998 |
129 | GDP-mannose metabolic process (GO:0019673) | 2.35359498 |
130 | carnitine shuttle (GO:0006853) | 2.34112404 |
131 | positive regulation of lipid catabolic process (GO:0050996) | 2.33231386 |
132 | phosphate ion transport (GO:0006817) | 2.32969055 |
133 | dicarboxylic acid catabolic process (GO:0043649) | 2.31961471 |
134 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.30954885 |
135 | glyoxylate metabolic process (GO:0046487) | 2.30824910 |
136 | regulation of histone deacetylation (GO:0031063) | 2.30815669 |
137 | sulfur amino acid catabolic process (GO:0000098) | 2.29908086 |
138 | fatty acid transmembrane transport (GO:1902001) | 2.29646999 |
139 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.28632827 |
140 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.28510481 |
141 | regulation of fatty acid oxidation (GO:0046320) | 2.28503153 |
142 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.27239239 |
143 | cellular ketone body metabolic process (GO:0046950) | 2.27054466 |
144 | drug catabolic process (GO:0042737) | 2.26341630 |
145 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.26204007 |
146 | apoptotic process involved in development (GO:1902742) | 2.26196269 |
147 | establishment of apical/basal cell polarity (GO:0035089) | 2.26188768 |
148 | negative regulation of myotube differentiation (GO:0010832) | 2.26022398 |
149 | barbed-end actin filament capping (GO:0051016) | 2.26020073 |
150 | protein targeting to plasma membrane (GO:0072661) | 2.25091266 |
151 | cerebellar granule cell differentiation (GO:0021707) | 2.24640785 |
152 | proline biosynthetic process (GO:0006561) | 2.24443532 |
153 | negative regulation of viral release from host cell (GO:1902187) | 2.24124946 |
154 | glucose 6-phosphate metabolic process (GO:0051156) | 2.24080000 |
155 | osteoblast development (GO:0002076) | 2.23735317 |
156 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.22805447 |
157 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.21668653 |
158 | protein heterotrimerization (GO:0070208) | 2.20863641 |
159 | tooth mineralization (GO:0034505) | 2.20561683 |
160 | skeletal muscle organ development (GO:0060538) | 2.19916021 |
161 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.19807554 |
162 | establishment of nucleus localization (GO:0040023) | 2.19788635 |
163 | regulation of early endosome to late endosome transport (GO:2000641) | 2.19508776 |
164 | negative regulation of lipid transport (GO:0032369) | 2.19169647 |
165 | positive regulation of receptor recycling (GO:0001921) | 2.19120074 |
166 | receptor catabolic process (GO:0032801) | 2.18697420 |
167 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.17638335 |
168 | nitrogen cycle metabolic process (GO:0071941) | 2.17325490 |
169 | high-density lipoprotein particle remodeling (GO:0034375) | 2.17302536 |
170 | regulation of triglyceride catabolic process (GO:0010896) | 2.16190220 |
171 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.15353888 |
172 | signal complex assembly (GO:0007172) | 2.13702646 |
173 | convergent extension (GO:0060026) | 2.13676478 |
174 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.13655171 |
175 | synaptic vesicle endocytosis (GO:0048488) | 2.13570154 |
176 | platelet formation (GO:0030220) | 2.12847539 |
177 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.12801555 |
178 | long-term memory (GO:0007616) | 2.12262670 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.62648998 |
2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.94696286 |
3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.75702405 |
4 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.72562132 |
5 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.69335014 |
6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.50300840 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.45694905 |
8 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.38947584 |
9 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.36750046 |
10 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.34333374 |
11 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.34003939 |
12 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.27441094 |
13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.18936192 |
14 | KDM2B_26808549_Chip-Seq_K562_Human | 2.13904718 |
15 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.11280014 |
16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.02948395 |
17 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.01696987 |
18 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.97335308 |
19 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.94657738 |
20 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.89823425 |
21 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.89078735 |
22 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.88022521 |
23 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.87016053 |
24 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.86606186 |
25 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.81421596 |
26 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.75139661 |
27 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.73138377 |
28 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.72187493 |
29 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.69341456 |
30 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.66884339 |
31 | MYC_22102868_ChIP-Seq_BL_Human | 1.65133488 |
32 | GATA1_19941826_ChIP-Seq_K562_Human | 1.63318445 |
33 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.61487473 |
34 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.58880585 |
35 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.56791313 |
36 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.55488863 |
37 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.55180096 |
38 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.53925318 |
39 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.53237886 |
40 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.52878589 |
41 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.51569734 |
42 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.48818246 |
43 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.45916747 |
44 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.45881429 |
45 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.44208744 |
46 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.41581518 |
47 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.40477679 |
48 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.40477679 |
49 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.40437766 |
50 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.39106948 |
51 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.38847142 |
52 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.38533439 |
53 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.38390709 |
54 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.35623131 |
55 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.35417051 |
56 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.33923620 |
57 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.32555706 |
58 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.32284444 |
59 | P68_20966046_ChIP-Seq_HELA_Human | 1.31816227 |
60 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.29256189 |
61 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.28519978 |
62 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.27484744 |
63 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.26849847 |
64 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.25222781 |
65 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.24760635 |
66 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.24624020 |
67 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.24594478 |
68 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23573763 |
69 | SA1_27219007_Chip-Seq_Bcells_Human | 1.22662684 |
70 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22429329 |
71 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22349965 |
72 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.21738936 |
73 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.20314812 |
74 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.20290054 |
75 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.20192743 |
76 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.19926986 |
77 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.19512236 |
78 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.18697671 |
79 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.16429229 |
80 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.15644400 |
81 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.15399271 |
82 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.14199727 |
83 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.13446530 |
84 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.13309383 |
85 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.13144438 |
86 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.12669456 |
87 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12428475 |
88 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.12300375 |
89 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 1.11293101 |
90 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.11262114 |
91 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.10993755 |
92 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.10077933 |
93 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.09709803 |
94 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.09363668 |
95 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.09201109 |
96 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.09038002 |
97 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.08534851 |
98 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.08477080 |
99 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.08210755 |
100 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.08207038 |
101 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.07889357 |
102 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07718441 |
103 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.06794179 |
104 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.06290477 |
105 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.05612076 |
106 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05217862 |
107 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04926683 |
108 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.04019093 |
109 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.03981887 |
110 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.03952495 |
111 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.03434457 |
112 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.03093208 |
113 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02894094 |
114 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.02836907 |
115 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.02396595 |
116 | * SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.02069616 |
117 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.01384198 |
118 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.01384198 |
119 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.00435127 |
120 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.99544834 |
121 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.98854627 |
122 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.98633461 |
123 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.98470951 |
124 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.96977847 |
125 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.96785916 |
126 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96067985 |
127 | ATF3_27146783_Chip-Seq_COLON_Human | 0.95093054 |
128 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.94593019 |
129 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.93667681 |
130 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.92127004 |
131 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.91754571 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 5.43346709 |
2 | MP0005360_urolithiasis | 3.87925611 |
3 | MP0002139_abnormal_hepatobiliary_system | 3.37839169 |
4 | MP0003705_abnormal_hypodermis_morpholog | 3.04922602 |
5 | MP0005085_abnormal_gallbladder_physiolo | 2.76335501 |
6 | MP0005409_darkened_coat_color | 2.66613719 |
7 | MP0002822_catalepsy | 2.55603911 |
8 | MP0002249_abnormal_larynx_morphology | 2.50048017 |
9 | MP0003635_abnormal_synaptic_transmissio | 2.49690785 |
10 | MP0009840_abnormal_foam_cell | 2.38606428 |
11 | MP0008961_abnormal_basal_metabolism | 2.38515426 |
12 | MP0005451_abnormal_body_composition | 2.38045198 |
13 | MP0005365_abnormal_bile_salt | 2.37820318 |
14 | MP0000678_abnormal_parathyroid_gland | 2.32713814 |
15 | MP0003329_amyloid_beta_deposits | 2.21720309 |
16 | MP0005083_abnormal_biliary_tract | 2.18149112 |
17 | MP0005670_abnormal_white_adipose | 2.17543000 |
18 | MP0009780_abnormal_chondrocyte_physiolo | 2.12614663 |
19 | MP0002909_abnormal_adrenal_gland | 2.07237935 |
20 | MP0010329_abnormal_lipoprotein_level | 2.06761535 |
21 | MP0004270_analgesia | 2.05621952 |
22 | MP0004130_abnormal_muscle_cell | 2.05204912 |
23 | MP0000566_synostosis | 2.02789593 |
24 | MP0004858_abnormal_nervous_system | 2.00492874 |
25 | MP0002837_dystrophic_cardiac_calcinosis | 1.99831956 |
26 | MP0001348_abnormal_lacrimal_gland | 1.98138376 |
27 | MP0002063_abnormal_learning/memory/cond | 1.95965091 |
28 | MP0010234_abnormal_vibrissa_follicle | 1.93990783 |
29 | MP0005058_abnormal_lysosome_morphology | 1.93491463 |
30 | MP0003252_abnormal_bile_duct | 1.89750258 |
31 | MP0008875_abnormal_xenobiotic_pharmacok | 1.88593970 |
32 | MP0003191_abnormal_cellular_cholesterol | 1.88119875 |
33 | MP0000751_myopathy | 1.85678187 |
34 | MP0003300_gastrointestinal_ulcer | 1.81564544 |
35 | MP0001958_emphysema | 1.74055695 |
36 | MP0003656_abnormal_erythrocyte_physiolo | 1.72683863 |
37 | MP0008438_abnormal_cutaneous_collagen | 1.70944919 |
38 | MP0002064_seizures | 1.70097986 |
39 | MP0009745_abnormal_behavioral_response | 1.67052845 |
40 | MP0003075_altered_response_to | 1.65384402 |
41 | MP0003283_abnormal_digestive_organ | 1.56802676 |
42 | MP0005257_abnormal_intraocular_pressure | 1.56202332 |
43 | MP0000604_amyloidosis | 1.51109182 |
44 | MP0004885_abnormal_endolymph | 1.51066274 |
45 | MP0001664_abnormal_digestion | 1.49689301 |
46 | MP0003566_abnormal_cell_adhesion | 1.48884278 |
47 | MP0000537_abnormal_urethra_morphology | 1.47853424 |
48 | MP0003879_abnormal_hair_cell | 1.46225803 |
49 | MP0003279_aneurysm | 1.44400469 |
50 | MP0005167_abnormal_blood-brain_barrier | 1.43383251 |
51 | MP0003303_peritoneal_inflammation | 1.39953038 |
52 | MP0001666_abnormal_nutrient_absorption | 1.38364402 |
53 | MP0008569_lethality_at_weaning | 1.36525154 |
54 | MP0002118_abnormal_lipid_homeostasis | 1.30794848 |
55 | MP0004510_myositis | 1.30181917 |
56 | MP0000534_abnormal_ureter_morphology | 1.29639870 |
57 | MP0009379_abnormal_foot_pigmentation | 1.29051418 |
58 | MP0005332_abnormal_amino_acid | 1.26900631 |
59 | MP0000747_muscle_weakness | 1.26076535 |
60 | MP0001440_abnormal_grooming_behavior | 1.25118928 |
61 | MP0003453_abnormal_keratinocyte_physiol | 1.23618722 |
62 | MP0004811_abnormal_neuron_physiology | 1.20275711 |
63 | MP0003646_muscle_fatigue | 1.20202129 |
64 | MP0002572_abnormal_emotion/affect_behav | 1.19982538 |
65 | MP0004185_abnormal_adipocyte_glucose | 1.19580155 |
66 | MP0002796_impaired_skin_barrier | 1.18988792 |
67 | MP0010030_abnormal_orbit_morphology | 1.18929101 |
68 | MP0004087_abnormal_muscle_fiber | 1.17298972 |
69 | MP0003091_abnormal_cell_migration | 1.14548838 |
70 | MP0008874_decreased_physiological_sensi | 1.13881153 |
71 | MP0006138_congestive_heart_failure | 1.13494858 |
72 | MP0000538_abnormal_urinary_bladder | 1.12690320 |
73 | MP0003633_abnormal_nervous_system | 1.10938920 |
74 | MP0009278_abnormal_bone_marrow | 1.10442965 |
75 | MP0005666_abnormal_adipose_tissue | 1.09558408 |
76 | MP0001502_abnormal_circadian_rhythm | 1.09222167 |
77 | MP0000609_abnormal_liver_physiology | 1.09146032 |
78 | MP0009046_muscle_twitch | 1.08595250 |
79 | MP0005330_cardiomyopathy | 1.08477083 |
80 | MP0000733_abnormal_muscle_development | 1.07555171 |
81 | MP0009384_cardiac_valve_regurgitation | 1.07114784 |
82 | MP0003172_abnormal_lysosome_physiology | 1.06713915 |
83 | MP0002269_muscular_atrophy | 1.06010072 |
84 | MP0000467_abnormal_esophagus_morphology | 1.04451634 |
85 | MP0009053_abnormal_anal_canal | 1.04448345 |
86 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.03257502 |
87 | MP0000750_abnormal_muscle_regeneration | 1.03190770 |
88 | MP0008872_abnormal_physiological_respon | 1.02486740 |
89 | MP0003123_paternal_imprinting | 1.02064021 |
90 | MP0005535_abnormal_body_temperature | 1.01634657 |
91 | MP0005375_adipose_tissue_phenotype | 1.01262955 |
92 | MP0003690_abnormal_glial_cell | 1.01160494 |
93 | MP0005166_decreased_susceptibility_to | 0.99999354 |
94 | MP0001968_abnormal_touch/_nociception | 0.98994824 |
95 | MP0002896_abnormal_bone_mineralization | 0.98232114 |
96 | MP0004043_abnormal_pH_regulation | 0.98221946 |
97 | MP0002733_abnormal_thermal_nociception | 0.96567229 |
98 | MP0004272_abnormal_basement_membrane | 0.96325641 |
99 | MP0001873_stomach_inflammation | 0.96262437 |
100 | MP0004084_abnormal_cardiac_muscle | 0.95914101 |
101 | MP0004215_abnormal_myocardial_fiber | 0.95464478 |
102 | MP0000003_abnormal_adipose_tissue | 0.95256890 |
103 | MP0003880_abnormal_central_pattern | 0.95105901 |
104 | MP0005423_abnormal_somatic_nervous | 0.95075321 |
105 | MP0004264_abnormal_extraembryonic_tissu | 0.93683827 |
106 | MP0000767_abnormal_smooth_muscle | 0.91068145 |
107 | MP0004233_abnormal_muscle_weight | 0.90940554 |
108 | MP0002734_abnormal_mechanical_nocicepti | 0.90287220 |
109 | MP0004036_abnormal_muscle_relaxation | 0.89901521 |
110 | MP0005501_abnormal_skin_physiology | 0.89572407 |
111 | MP0003183_abnormal_peptide_metabolism | 0.89438176 |
112 | MP0005319_abnormal_enzyme/_coenzyme | 0.89153209 |
113 | MP0001501_abnormal_sleep_pattern | 0.88108368 |
114 | MP0003137_abnormal_impulse_conducting | 0.87530578 |
115 | MP0002078_abnormal_glucose_homeostasis | 0.86659677 |
116 | MP0001765_abnormal_ion_homeostasis | 0.86645503 |
117 | MP0001486_abnormal_startle_reflex | 0.86034665 |
118 | MP0002877_abnormal_melanocyte_morpholog | 0.86026815 |
119 | MP0004085_abnormal_heartbeat | 0.85943636 |
120 | MP0000462_abnormal_digestive_system | 0.85750372 |
121 | MP0002272_abnormal_nervous_system | 0.84873303 |
122 | MP0003634_abnormal_glial_cell | 0.83949383 |
123 | MP0003045_fibrosis | 0.82586622 |
124 | MP0005448_abnormal_energy_balance | 0.82558218 |
125 | MP0004145_abnormal_muscle_electrophysio | 0.82258642 |
126 | MP0002089_abnormal_postnatal_growth/wei | 0.81959071 |
127 | MP0005023_abnormal_wound_healing | 0.81904011 |
128 | MP0000955_abnormal_spinal_cord | 0.80666310 |
129 | MP0004484_altered_response_of | 0.80665910 |
130 | MP0000681_abnormal_thyroid_gland | 0.79863000 |
131 | MP0005076_abnormal_cell_differentiation | 0.78529551 |
132 | MP0002098_abnormal_vibrissa_morphology | 0.77753962 |
133 | MP0003631_nervous_system_phenotype | 0.77289437 |
134 | MP0001970_abnormal_pain_threshold | 0.76957191 |
135 | MP0000749_muscle_degeneration | 0.76708312 |
136 | MP0002932_abnormal_joint_morphology | 0.76442749 |
137 | MP0005381_digestive/alimentary_phenotyp | 0.76322464 |
138 | MP0005503_abnormal_tendon_morphology | 0.75842260 |
139 | MP0002066_abnormal_motor_capabilities/c | 0.75670374 |
140 | MP0005595_abnormal_vascular_smooth | 0.75277905 |
141 | MP0001849_ear_inflammation | 0.73959521 |
142 | MP0005620_abnormal_muscle_contractility | 0.73561897 |
143 | MP0003195_calcinosis | 0.73465828 |
144 | MP0002254_reproductive_system_inflammat | 0.73221793 |
145 | MP0005508_abnormal_skeleton_morphology | 0.72755124 |
146 | MP0000579_abnormal_nail_morphology | 0.72603360 |
147 | MP0010630_abnormal_cardiac_muscle | 0.72404688 |
148 | MP0003942_abnormal_urinary_system | 0.71212282 |
149 | MP0004924_abnormal_behavior | 0.70758423 |
150 | MP0005386_behavior/neurological_phenoty | 0.70758423 |
151 | MP0000470_abnormal_stomach_morphology | 0.70722635 |
152 | MP0002069_abnormal_eating/drinking_beha | 0.70659530 |
153 | MP0002971_abnormal_brown_adipose | 0.70285727 |
154 | MP0000759_abnormal_skeletal_muscle | 0.69901244 |
155 | MP0000013_abnormal_adipose_tissue | 0.69799642 |
156 | MP0005623_abnormal_meninges_morphology | 0.69371872 |
157 | MP0004019_abnormal_vitamin_homeostasis | 0.68993056 |
158 | MP0002998_abnormal_bone_remodeling | 0.67604601 |
159 | MP0002653_abnormal_ependyma_morphology | 0.66511608 |
160 | MP0001663_abnormal_digestive_system | 0.66371344 |
161 | MP0002060_abnormal_skin_morphology | 0.65845585 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Obstructive sleep apnea (HP:0002870) | 3.99404222 |
2 | Myokymia (HP:0002411) | 3.85721845 |
3 | Abnormality of the lower motor neuron (HP:0002366) | 3.40963938 |
4 | Reticulocytosis (HP:0001923) | 3.37757354 |
5 | Deep venous thrombosis (HP:0002625) | 3.37418423 |
6 | Protrusio acetabuli (HP:0003179) | 3.28098328 |
7 | Shallow orbits (HP:0000586) | 3.22457714 |
8 | Ulnar bowing (HP:0003031) | 3.11617261 |
9 | Distal lower limb amyotrophy (HP:0008944) | 3.09294962 |
10 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.08114966 |
11 | Bronchomalacia (HP:0002780) | 3.03742779 |
12 | Polycythemia (HP:0001901) | 3.00940227 |
13 | Visual hallucinations (HP:0002367) | 2.99413973 |
14 | Broad face (HP:0000283) | 2.97425709 |
15 | Bundle branch block (HP:0011710) | 2.96149425 |
16 | Stridor (HP:0010307) | 2.86717136 |
17 | Hemorrhage of the eye (HP:0011885) | 2.84327166 |
18 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.83788539 |
19 | Increased connective tissue (HP:0009025) | 2.83294905 |
20 | Abnormality of the Achilles tendon (HP:0005109) | 2.82704827 |
21 | Ventricular fibrillation (HP:0001663) | 2.82449244 |
22 | Xanthomatosis (HP:0000991) | 2.81816255 |
23 | Thin bony cortex (HP:0002753) | 2.81592103 |
24 | Insomnia (HP:0100785) | 2.78641122 |
25 | Acanthocytosis (HP:0001927) | 2.77865928 |
26 | Dysmetric saccades (HP:0000641) | 2.70572173 |
27 | Myopathic facies (HP:0002058) | 2.67296874 |
28 | Premature rupture of membranes (HP:0001788) | 2.66849679 |
29 | Achilles tendon contracture (HP:0001771) | 2.66557823 |
30 | Sudden death (HP:0001699) | 2.63776084 |
31 | Poikilocytosis (HP:0004447) | 2.61752322 |
32 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.60153899 |
33 | Broad metatarsal (HP:0001783) | 2.59610732 |
34 | Exercise-induced myalgia (HP:0003738) | 2.59530931 |
35 | Supranuclear gaze palsy (HP:0000605) | 2.56847149 |
36 | Focal seizures (HP:0007359) | 2.54007328 |
37 | Postural instability (HP:0002172) | 2.53071968 |
38 | Gout (HP:0001997) | 2.50781419 |
39 | Abnormal social behavior (HP:0012433) | 2.48789606 |
40 | Impaired social interactions (HP:0000735) | 2.48789606 |
41 | Distal lower limb muscle weakness (HP:0009053) | 2.47427030 |
42 | Fragile skin (HP:0001030) | 2.47175972 |
43 | Hyperacusis (HP:0010780) | 2.44249992 |
44 | Ketosis (HP:0001946) | 2.43951911 |
45 | Increased cerebral lipofuscin (HP:0011813) | 2.43349929 |
46 | Cholelithiasis (HP:0001081) | 2.41115741 |
47 | Depression (HP:0000716) | 2.41100107 |
48 | Upper limb amyotrophy (HP:0009129) | 2.37142387 |
49 | Distal upper limb amyotrophy (HP:0007149) | 2.37142387 |
50 | Disproportionate tall stature (HP:0001519) | 2.35242834 |
51 | Cerebral inclusion bodies (HP:0100314) | 2.33124261 |
52 | Type 1 muscle fiber predominance (HP:0003803) | 2.31735964 |
53 | Ketoacidosis (HP:0001993) | 2.31242447 |
54 | Bladder diverticulum (HP:0000015) | 2.29156928 |
55 | Focal motor seizures (HP:0011153) | 2.28247348 |
56 | Complement deficiency (HP:0004431) | 2.28115277 |
57 | Myoglobinuria (HP:0002913) | 2.26447962 |
58 | Breast hypoplasia (HP:0003187) | 2.25744582 |
59 | Rectal prolapse (HP:0002035) | 2.25002160 |
60 | Action tremor (HP:0002345) | 2.24852985 |
61 | Lymphangioma (HP:0100764) | 2.23233877 |
62 | Spinal rigidity (HP:0003306) | 2.22449496 |
63 | Status epilepticus (HP:0002133) | 2.22070044 |
64 | Global brain atrophy (HP:0002283) | 2.18609578 |
65 | Poor eye contact (HP:0000817) | 2.18316470 |
66 | Resting tremor (HP:0002322) | 2.17723147 |
67 | Hemiplegia (HP:0002301) | 2.17306991 |
68 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.16034900 |
69 | Cholecystitis (HP:0001082) | 2.13711185 |
70 | Abnormal gallbladder physiology (HP:0012438) | 2.13711185 |
71 | Abnormal gallbladder morphology (HP:0012437) | 2.13603498 |
72 | Exercise-induced muscle cramps (HP:0003710) | 2.13523960 |
73 | Torticollis (HP:0000473) | 2.12747943 |
74 | Bowed forearm bones (HP:0003956) | 2.11033173 |
75 | Bowing of the arm (HP:0006488) | 2.11033173 |
76 | Difficulty running (HP:0009046) | 2.10550513 |
77 | Hypoventilation (HP:0002791) | 2.09403754 |
78 | Asymmetric septal hypertrophy (HP:0001670) | 2.07169068 |
79 | Abnormality of proline metabolism (HP:0010907) | 2.07058842 |
80 | Hydroxyprolinuria (HP:0003080) | 2.07058842 |
81 | Urinary urgency (HP:0000012) | 2.05998694 |
82 | Increased variability in muscle fiber diameter (HP:0003557) | 2.05592073 |
83 | Ankle clonus (HP:0011448) | 2.04787515 |
84 | Heart block (HP:0012722) | 2.04471089 |
85 | Genu recurvatum (HP:0002816) | 2.04267458 |
86 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.03959775 |
87 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.02889173 |
88 | Hand muscle atrophy (HP:0009130) | 2.02062566 |
89 | Cervical subluxation (HP:0003308) | 2.01936008 |
90 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.01038943 |
91 | Neonatal onset (HP:0003623) | 2.00528714 |
92 | Hyperparathyroidism (HP:0000843) | 2.00422158 |
93 | Cerebral aneurysm (HP:0004944) | 2.00333979 |
94 | Easy fatigability (HP:0003388) | 2.00238259 |
95 | Bulbar palsy (HP:0001283) | 2.00236357 |
96 | Papilledema (HP:0001085) | 1.99306789 |
97 | Atrioventricular block (HP:0001678) | 1.99214415 |
98 | Hyperammonemia (HP:0001987) | 1.98858982 |
99 | Intrahepatic cholestasis (HP:0001406) | 1.98348931 |
100 | Mitral regurgitation (HP:0001653) | 1.98248584 |
101 | Abnormal atrioventricular conduction (HP:0005150) | 1.97545438 |
102 | Rapidly progressive (HP:0003678) | 1.96226529 |
103 | Onion bulb formation (HP:0003383) | 1.95443898 |
104 | Hyperlipoproteinemia (HP:0010980) | 1.95155260 |
105 | Turricephaly (HP:0000262) | 1.94914051 |
106 | Malnutrition (HP:0004395) | 1.94639918 |
107 | Lower limb amyotrophy (HP:0007210) | 1.94006197 |
108 | Focal dystonia (HP:0004373) | 1.94000314 |
109 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.92300007 |
110 | Flat acetabular roof (HP:0003180) | 1.91252812 |
111 | Right ventricular cardiomyopathy (HP:0011663) | 1.91173584 |
112 | Hyporeflexia of lower limbs (HP:0002600) | 1.90460630 |
113 | Generalized tonic-clonic seizures (HP:0002069) | 1.89650340 |
114 | Annular pancreas (HP:0001734) | 1.89053831 |
115 | Elfin facies (HP:0004428) | 1.88397677 |
116 | Hypoalphalipoproteinemia (HP:0003233) | 1.87943670 |
117 | Ventricular arrhythmia (HP:0004308) | 1.87339677 |
118 | Blue sclerae (HP:0000592) | 1.86423868 |
119 | Round ear (HP:0100830) | 1.85717031 |
120 | Thin ribs (HP:0000883) | 1.85583893 |
121 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.84644536 |
122 | Renovascular hypertension (HP:0100817) | 1.84066300 |
123 | Aneurysm (HP:0002617) | 1.84030662 |
124 | Hypercortisolism (HP:0001578) | 1.83639748 |
125 | Hyperbilirubinemia (HP:0002904) | 1.83369533 |
126 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.83076596 |
127 | Intention tremor (HP:0002080) | 1.82755825 |
128 | Craniofacial dystonia (HP:0012179) | 1.82566827 |
129 | Pointed chin (HP:0000307) | 1.82536250 |
130 | Coxa vara (HP:0002812) | 1.82528686 |
131 | Sensorimotor neuropathy (HP:0007141) | 1.81602232 |
132 | Dysdiadochokinesis (HP:0002075) | 1.81449434 |
133 | Long palpebral fissure (HP:0000637) | 1.81113179 |
134 | Hamartoma of the eye (HP:0010568) | 1.80115296 |
135 | Syncope (HP:0001279) | 1.79577469 |
136 | Vertebral compression fractures (HP:0002953) | 1.77143074 |
137 | Difficulty climbing stairs (HP:0003551) | 1.77033981 |
138 | Neurofibrillary tangles (HP:0002185) | 1.76455199 |
139 | Epidermoid cyst (HP:0200040) | 1.75837475 |
140 | Clumsiness (HP:0002312) | 1.75489551 |
141 | Abnormality of the aortic arch (HP:0012303) | 1.75315212 |
142 | Renal duplication (HP:0000075) | 1.75281093 |
143 | Macroorchidism (HP:0000053) | 1.75094137 |
144 | Anxiety (HP:0000739) | 1.75082862 |
145 | Abnormality of binocular vision (HP:0011514) | 1.74937797 |
146 | Diplopia (HP:0000651) | 1.74937797 |
147 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.74584187 |
148 | Aplasia of the phalanges of the hand (HP:0009802) | 1.74584187 |
149 | Aplasia involving bones of the extremities (HP:0009825) | 1.74584187 |
150 | Termporal pattern (HP:0011008) | 1.73455956 |
151 | Insidious onset (HP:0003587) | 1.73455956 |
152 | J-shaped sella turcica (HP:0002680) | 1.73297866 |
153 | Polygenic inheritance (HP:0010982) | 1.73166073 |
154 | Abnormality of complement system (HP:0005339) | 1.72763529 |
155 | Late onset (HP:0003584) | 1.72662362 |
156 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.72630248 |
157 | Atrophic scars (HP:0001075) | 1.71828012 |
158 | Generalized amyotrophy (HP:0003700) | 1.70212938 |
159 | Ileus (HP:0002595) | 1.69146852 |
160 | Hyperglycinuria (HP:0003108) | 1.68590251 |
161 | Axonal loss (HP:0003447) | 1.68517925 |
162 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.67417299 |
163 | Coronal craniosynostosis (HP:0004440) | 1.67265375 |
164 | Overriding aorta (HP:0002623) | 1.66783419 |
165 | Abdominal distention (HP:0003270) | 1.66461047 |
166 | Flat cornea (HP:0007720) | 1.65937201 |
167 | Skin nodule (HP:0200036) | 1.65418668 |
168 | Ankle contracture (HP:0006466) | 1.64658658 |
169 | Back pain (HP:0003418) | 1.64313337 |
170 | Premature skin wrinkling (HP:0100678) | 1.60917542 |
171 | Joint stiffness (HP:0001387) | 1.58777947 |
172 | Hyperextensible skin (HP:0000974) | 1.58748578 |
173 | Abnormality of the fingertips (HP:0001211) | 1.58718181 |
174 | Broad distal phalanx of finger (HP:0009836) | 1.58642616 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 4.10574570 |
2 | MAP3K9 | 3.02603820 |
3 | PKN2 | 3.02056092 |
4 | EPHA2 | 2.89403111 |
5 | PRKD3 | 2.52298727 |
6 | DAPK2 | 2.48223220 |
7 | IRAK3 | 2.43571209 |
8 | SMG1 | 2.41281109 |
9 | EPHA4 | 2.34943863 |
10 | KSR2 | 2.33600899 |
11 | RIPK1 | 2.09628904 |
12 | MAP3K10 | 2.08378525 |
13 | PAK6 | 2.06816269 |
14 | TAOK1 | 2.04098305 |
15 | ERN1 | 2.03390357 |
16 | CAMKK1 | 1.99527808 |
17 | MST1R | 1.92293152 |
18 | NTRK3 | 1.85257407 |
19 | ICK | 1.81642671 |
20 | SIK2 | 1.69948190 |
21 | EEF2K | 1.52248391 |
22 | LMTK2 | 1.52140659 |
23 | CDK12 | 1.47851437 |
24 | MINK1 | 1.47635324 |
25 | ALK | 1.42612827 |
26 | TYRO3 | 1.40488571 |
27 | STK38 | 1.38377471 |
28 | MAP3K4 | 1.35376847 |
29 | NEK1 | 1.35158215 |
30 | MARK1 | 1.32833337 |
31 | NTRK1 | 1.31707615 |
32 | MAP3K7 | 1.30909648 |
33 | SIK1 | 1.30403497 |
34 | MAP2K4 | 1.30334016 |
35 | PTK6 | 1.29958808 |
36 | BMX | 1.29360768 |
37 | TTN | 1.28218424 |
38 | PRKG2 | 1.25322366 |
39 | PRKCH | 1.23722312 |
40 | RET | 1.21117804 |
41 | PHKG2 | 1.20139079 |
42 | PHKG1 | 1.20139079 |
43 | MAP3K2 | 1.16402582 |
44 | PDGFRA | 1.14622548 |
45 | EPHB2 | 1.09794213 |
46 | MET | 1.09136209 |
47 | PAK4 | 1.06624342 |
48 | KSR1 | 1.06454769 |
49 | EPHB1 | 1.04181179 |
50 | ARAF | 1.03392139 |
51 | DMPK | 1.01232670 |
52 | NTRK2 | 1.00775875 |
53 | MAPKAPK3 | 0.98481809 |
54 | CDK5 | 0.97782544 |
55 | BCKDK | 0.97758423 |
56 | MAP2K2 | 0.97574392 |
57 | PDPK1 | 0.97093475 |
58 | LATS2 | 0.94371450 |
59 | STK11 | 0.94353199 |
60 | MAP3K1 | 0.92873657 |
61 | CAMK1G | 0.92131689 |
62 | SGK3 | 0.91563309 |
63 | PDK1 | 0.91311217 |
64 | IRAK2 | 0.89725182 |
65 | TESK1 | 0.89626735 |
66 | GRK6 | 0.86012817 |
67 | DAPK1 | 0.85754435 |
68 | UHMK1 | 0.85711036 |
69 | RPS6KA6 | 0.83177083 |
70 | SCYL2 | 0.81949458 |
71 | MAP2K3 | 0.81837051 |
72 | RPS6KL1 | 0.81234358 |
73 | RPS6KC1 | 0.81234358 |
74 | PAK3 | 0.74803815 |
75 | MARK2 | 0.74392887 |
76 | TAOK2 | 0.72765327 |
77 | BRAF | 0.72394110 |
78 | MAP3K13 | 0.72158853 |
79 | PINK1 | 0.70659707 |
80 | RPS6KA2 | 0.69145180 |
81 | MAP3K11 | 0.68690549 |
82 | FGFR4 | 0.67905028 |
83 | MUSK | 0.66887305 |
84 | HIPK2 | 0.66610142 |
85 | CAMK4 | 0.66442460 |
86 | CAMK1D | 0.66111939 |
87 | JAK2 | 0.64328118 |
88 | PTK2B | 0.64098531 |
89 | DAPK3 | 0.63017145 |
90 | CAMK1 | 0.62458106 |
91 | MAPK11 | 0.62170517 |
92 | MAP3K3 | 0.62076006 |
93 | CDC42BPA | 0.61857278 |
94 | PTK2 | 0.59927102 |
95 | RIPK4 | 0.59877195 |
96 | MAPK12 | 0.59677457 |
97 | FES | 0.59559017 |
98 | TNK2 | 0.59076081 |
99 | MAP2K1 | 0.58934340 |
100 | PRKD1 | 0.58761228 |
101 | LRRK2 | 0.56933223 |
102 | PRKCZ | 0.56423185 |
103 | IRAK4 | 0.55877352 |
104 | PRKAA1 | 0.55360032 |
105 | PRKCG | 0.54920090 |
106 | MAP2K6 | 0.54562309 |
107 | MTOR | 0.53163523 |
108 | TESK2 | 0.52904457 |
109 | ERBB2 | 0.51180749 |
110 | PRKD2 | 0.50697073 |
111 | RPS6KA3 | 0.48000064 |
112 | DDR2 | 0.47619721 |
113 | GRK5 | 0.47461431 |
114 | CDK15 | 0.47104581 |
115 | SGK1 | 0.46882567 |
116 | DYRK1B | 0.46433442 |
117 | PRKCI | 0.45730462 |
118 | PDK4 | 0.45280421 |
119 | PDK3 | 0.45280421 |
120 | MAP4K1 | 0.44703975 |
121 | LIMK1 | 0.44296449 |
122 | WNK4 | 0.42236055 |
123 | RPS6KA1 | 0.42080932 |
124 | CDK18 | 0.41998728 |
125 | CDK11A | 0.41118429 |
126 | MAPK15 | 0.40610655 |
127 | ILK | 0.40179695 |
128 | JAK1 | 0.39845720 |
129 | PRPF4B | 0.39820484 |
130 | CAMK2B | 0.39675781 |
131 | CDK14 | 0.39377394 |
132 | FYN | 0.38478308 |
133 | PRKACG | 0.38178728 |
134 | CAMK2G | 0.38101254 |
135 | MAPK8 | 0.36471211 |
136 | NME2 | 0.35496210 |
137 | PDGFRB | 0.33013175 |
138 | PRKAA2 | 0.32775578 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.80500021 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.98411895 |
3 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.24094590 |
4 | Sulfur relay system_Homo sapiens_hsa04122 | 1.98941481 |
5 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.93329740 |
6 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.91943875 |
7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.83880096 |
8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.81884489 |
9 | Bile secretion_Homo sapiens_hsa04976 | 1.77300148 |
10 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.66496090 |
11 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.63295769 |
12 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.54791225 |
13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.42652339 |
14 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.40953193 |
15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.36202855 |
16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.36071038 |
17 | Olfactory transduction_Homo sapiens_hsa04740 | 1.35336453 |
18 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.34370106 |
19 | Other glycan degradation_Homo sapiens_hsa00511 | 1.34365170 |
20 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.30285357 |
21 | Long-term potentiation_Homo sapiens_hsa04720 | 1.29328562 |
22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.28522046 |
23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.27619143 |
24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.27429674 |
25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.24191564 |
26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.24035462 |
27 | Salivary secretion_Homo sapiens_hsa04970 | 1.20622478 |
28 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.20306541 |
29 | Circadian entrainment_Homo sapiens_hsa04713 | 1.19410206 |
30 | Insulin secretion_Homo sapiens_hsa04911 | 1.16979431 |
31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.16246359 |
32 | GABAergic synapse_Homo sapiens_hsa04727 | 1.13247721 |
33 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.10018171 |
34 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.09529435 |
35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.07326718 |
36 | Glioma_Homo sapiens_hsa05214 | 1.05599506 |
37 | Histidine metabolism_Homo sapiens_hsa00340 | 1.03223713 |
38 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.03134169 |
39 | Focal adhesion_Homo sapiens_hsa04510 | 1.00766044 |
40 | Lysine degradation_Homo sapiens_hsa00310 | 1.00137013 |
41 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.00073249 |
42 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.97186899 |
43 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.97014927 |
44 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.96486313 |
45 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.96223091 |
46 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.95808522 |
47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.95497089 |
48 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.93837337 |
49 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.92442541 |
50 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.92128742 |
51 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.91316696 |
52 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.90612029 |
53 | Carbon metabolism_Homo sapiens_hsa01200 | 0.90118511 |
54 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.89913208 |
55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.89546656 |
56 | Axon guidance_Homo sapiens_hsa04360 | 0.89036675 |
57 | Morphine addiction_Homo sapiens_hsa05032 | 0.88350275 |
58 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.88328926 |
59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87946776 |
60 | Insulin resistance_Homo sapiens_hsa04931 | 0.87760566 |
61 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.87195421 |
62 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.86967074 |
63 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.86341618 |
64 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.86211092 |
65 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.84540841 |
66 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.83805529 |
67 | Galactose metabolism_Homo sapiens_hsa00052 | 0.83759338 |
68 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.82351577 |
69 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.81479541 |
70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81273406 |
71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80430794 |
72 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.80278622 |
73 | Renin secretion_Homo sapiens_hsa04924 | 0.80030492 |
74 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.79402298 |
75 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.79196874 |
76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78673848 |
77 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.77859307 |
78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.77493207 |
79 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.77087975 |
80 | Nicotine addiction_Homo sapiens_hsa05033 | 0.74611005 |
81 | Gap junction_Homo sapiens_hsa04540 | 0.73958420 |
82 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.73345392 |
83 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.73313886 |
84 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.71265792 |
85 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.71254682 |
86 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.71215874 |
87 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.70989442 |
88 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70221327 |
89 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.70128377 |
90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69990944 |
91 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.69933523 |
92 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.69921466 |
93 | Mineral absorption_Homo sapiens_hsa04978 | 0.69749585 |
94 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.69045067 |
95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68099344 |
96 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.68027955 |
97 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.67347466 |
98 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.66719460 |
99 | Cocaine addiction_Homo sapiens_hsa05030 | 0.66646927 |
100 | Tight junction_Homo sapiens_hsa04530 | 0.65236716 |
101 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64706533 |
102 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.64639582 |
103 | Amoebiasis_Homo sapiens_hsa05146 | 0.64537564 |
104 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.63963546 |
105 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.63031163 |
106 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62755888 |
107 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62435032 |
108 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.62353254 |
109 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61948866 |
110 | Prion diseases_Homo sapiens_hsa05020 | 0.61648225 |
111 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.61229512 |
112 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60697899 |
113 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60627264 |
114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.60440559 |
115 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60373092 |
116 | ABC transporters_Homo sapiens_hsa02010 | 0.60089017 |
117 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.59299703 |
118 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.58364693 |
119 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58098955 |
120 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57922569 |
121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.57886510 |
122 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.57884507 |
123 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55801568 |
124 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.54412725 |
125 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.52791719 |
126 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.52183419 |
127 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48985394 |
128 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.48696655 |
129 | Long-term depression_Homo sapiens_hsa04730 | 0.47845169 |
130 | Melanogenesis_Homo sapiens_hsa04916 | 0.47247665 |
131 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.47169680 |
132 | Bladder cancer_Homo sapiens_hsa05219 | 0.47025386 |
133 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.46577509 |